vs
Amarin Corp plc（AMRN）与McEwen Inc.（MUX）财务数据对比。点击上方公司名可切换其他公司
McEwen Inc.的季度营收约是Amarin Corp plc的1.4倍（$64.6M vs $45.1M），McEwen Inc.净利率更高（59.0% vs -23.3%，领先82.3%），McEwen Inc.同比增速更快（92.8% vs 7.0%），过去两年McEwen Inc.的营收复合增速更高（25.2% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
McEwen Inc（股票代码MUX）是一家自然资源企业，主要从事金、银、铜矿产的勘探、开发与生产业务，运营项目分布于南北美洲，秉持可持续负责任的采矿准则，产品面向全球大宗商品市场供应。
AMRN vs MUX — 直观对比
营收规模更大
MUX
是对方的1.4倍
$45.1M
营收增速更快
MUX
高出85.8%
7.0%
净利率更高
MUX
高出82.3%
-23.3%
两年增速更快
MUX
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $64.6M |
| 净利润 | $-10.5M | $38.1M |
| 毛利率 | — | 26.9% |
| 营业利润率 | 35.5% | 34.2% |
| 净利率 | -23.3% | 59.0% |
| 营收同比 | 7.0% | 92.8% |
| 净利润同比 | 33.0% | 563.1% |
| 每股收益（稀释后） | — | $0.66 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNMUX
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $64.6M | ||
| Q3 25 | $49.7M | $50.5M | ||
| Q2 25 | $72.7M | $46.7M | ||
| Q1 25 | $42.0M | $35.7M | ||
| Q4 24 | $62.3M | $33.5M | ||
| Q3 24 | $42.3M | $52.3M | ||
| Q2 24 | $67.5M | $47.5M |
净利润AMRNMUX
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $38.1M | ||
| Q3 25 | $-7.7M | $-462.0K | ||
| Q2 25 | $-14.1M | $3.0M | ||
| Q1 25 | $-15.7M | $-6.3M | ||
| Q4 24 | $-48.6M | $-8.2M | ||
| Q3 24 | $-25.1M | $-2.1M | ||
| Q2 24 | $1.5M | $-13.0M |
毛利率AMRNMUX
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | 26.9% | ||
| Q3 25 | 44.7% | 15.5% | ||
| Q2 25 | 69.2% | 26.3% | ||
| Q1 25 | 59.8% | 28.2% | ||
| Q4 24 | -15.4% | 1.1% | ||
| Q3 24 | 38.5% | 26.4% | ||
| Q2 24 | 63.4% | 22.7% |
营业利润率AMRNMUX
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 34.2% | ||
| Q3 25 | -22.4% | -16.7% | ||
| Q2 25 | -22.0% | -7.2% | ||
| Q1 25 | -39.9% | -21.4% | ||
| Q4 24 | -84.3% | -43.4% | ||
| Q3 24 | -59.5% | -0.2% | ||
| Q2 24 | -0.8% | -29.4% |
净利率AMRNMUX
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | 59.0% | ||
| Q3 25 | -15.6% | -0.9% | ||
| Q2 25 | -19.4% | 6.5% | ||
| Q1 25 | -37.4% | -17.6% | ||
| Q4 24 | -78.0% | -24.6% | ||
| Q3 24 | -59.4% | -4.0% | ||
| Q2 24 | 2.3% | -27.4% |
每股收益（稀释后）AMRNMUX
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $0.66 | ||
| Q3 25 | $-0.02 | $-0.01 | ||
| Q2 25 | $-0.03 | $0.06 | ||
| Q1 25 | $-0.04 | $-0.12 | ||
| Q4 24 | $-0.12 | $-0.15 | ||
| Q3 24 | $-0.06 | $-0.04 | ||
| Q2 24 | $0.00 | $-0.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $72.1M |
| 总债务越低越好 | — | $126.2M |
| 股东权益账面价值 | — | $546.2M |
| 总资产 | $645.8M | $820.2M |
| 负债/权益比越低杠杆越低 | — | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资AMRNMUX
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $72.1M | ||
| Q3 25 | $286.6M | $75.4M | ||
| Q2 25 | $298.7M | $69.5M | ||
| Q1 25 | $281.8M | $79.3M | ||
| Q4 24 | $294.2M | $15.3M | ||
| Q3 24 | $305.7M | $30.2M | ||
| Q2 24 | $306.7M | $42.6M |
总债务AMRNMUX
| Q1 26 | — | — | ||
| Q4 25 | — | $126.2M | ||
| Q3 25 | — | $126.0M | ||
| Q2 25 | — | $125.8M | ||
| Q1 25 | — | $125.5M | ||
| Q4 24 | — | $40.0M | ||
| Q3 24 | — | $31.0M | ||
| Q2 24 | — | $34.0M |
股东权益AMRNMUX
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $546.2M | ||
| Q3 25 | $458.9M | $488.6M | ||
| Q2 25 | $464.9M | $484.5M | ||
| Q1 25 | $473.7M | $479.8M | ||
| Q4 24 | $486.2M | $495.0M | ||
| Q3 24 | $531.4M | $502.1M | ||
| Q2 24 | $551.9M | $485.2M |
总资产AMRNMUX
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $820.2M | ||
| Q3 25 | $659.8M | $747.6M | ||
| Q2 25 | $670.1M | $735.6M | ||
| Q1 25 | $655.7M | $730.6M | ||
| Q4 24 | $685.3M | $664.6M | ||
| Q3 24 | $750.6M | $667.8M | ||
| Q2 24 | $799.9M | $645.1M |
负债/权益比AMRNMUX
| Q1 26 | — | — | ||
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.26× | ||
| Q4 24 | — | 0.08× | ||
| Q3 24 | — | 0.06× | ||
| Q2 24 | — | 0.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $3.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AMRNMUX
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $3.1M | ||
| Q3 25 | $-12.7M | $5.2M | ||
| Q2 25 | $16.6M | $478.0K | ||
| Q1 25 | $-12.5M | $-1.9M | ||
| Q4 24 | $-13.3M | $-1.2M | ||
| Q3 24 | $-2.4M | $23.2M | ||
| Q2 24 | $-2.7M | $3.6M |
现金转化率AMRNMUX
| Q1 26 | — | — | ||
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.16× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.81× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
MUX
暂无分部数据
